mitomycin has been researched along with Hereditary Breast and Ovarian Cancer Syndrome in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Hereditary Breast and Ovarian Cancer Syndrome: Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wark, L | 1 |
| Novak, D | 1 |
| Sabbaghian, N | 1 |
| Amrein, L | 1 |
| Jangamreddy, JR | 1 |
| Cheang, M | 1 |
| Pouchet, C | 1 |
| Aloyz, R | 1 |
| Foulkes, WD | 1 |
| Mai, S | 1 |
| Tischkowitz, M | 1 |
1 other study available for mitomycin and Hereditary Breast and Ovarian Cancer Syndrome
| Article | Year |
|---|---|
Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
Topics: Adolescent; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, In | 2013 |